Thermo Fisher Launches Two New SARS-CoV-2 Antibody Tests to Further Broaden COVID-19 Test Portfolio
Thermo Fisher Scientific Inc. (Waltham, MA, USA) has launched two new SARS-CoV-2 antibody tests: the Thermo Scientific OmniPATH COVID-19 Total Antibody ELISA test, and the Thermo Scientific EliA SARS-CoV-2-Sp1 IgG test. More...13 Oct 2020
GenMark’s Combination Test for COVID-19, Flu, and Common Respiratory Illnesses Receives FDA EUA
GenMark Diagnostics, Inc. (Carlsbad, CA, USA) has received the US Food and Drug Administration’s (FDA) Emergency Use Authorization (EUA) for the company’s ePlex Respiratory Pathogen Panel 2 (RP2 Panel). More...12 Oct 2020
New Method Uses Simple Algebraic Equations to Enable Faster Processing of Large Volumes of COVID-19 Tests
A mathematician from Cardiff University has developed a new method for processing large volumes of COVID-19 tests which he believes could lead to significantly more tests being performed at once and results being returned much quicker. More...09 Oct 2020
New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
New
Histamine ELISA
Histamine ELISA
New
Thyroxine ELISA
T4 ELISA
In Other News
Low-Cost, Simple-to-Use, Ultrafast Point-of-Care COVID-19 Test to Provide RT PCR Results in 8 Minutes
Abbott Releases ID NOW COVID-19 Interim Clinical Study Results Confirming Test Sensitivity and Specificity
BioFire Diagnostics’ PCR-based SARS-CoV-2 Test Receives FDA Emergency Use Authorization
Thermo Fisher’s OmniPath COVID-19 Total Antibody ELISA Test for SARS-CoV-2 Granted FDA Emergency Use Authorization
Hologic Aptima SARS-CoV-2 Assay’s FDA EUA Amended to Include COVID-19 Testing of Asymptomatic Individuals, Symptomatic Sample Pooling
Mast Awarded Public Health England Tender for Exclusive Supply of AST and AMR Discs
New Dipstick Technology Could Offer Faster, Cheaper and Mobile COVID-19 Diagnosis
World’s First Assay Kit to Directly Profile SARS-CoV-2 Subgenomic RNA (sgRNA) from Clinical Samples Launched
Novel Rapid Antigen Assay Detects SARS-CoV-2 in Saliva in 10 Minutes
EKF Diagnostics’ PrimeStore MTM Successfully Evaluated by Public Health England for SARS-CoV-2 Inactivation
US Labs Increase COVID-19 Testing Capacity but Facing Shortage of Supplies, Finds NILA Survey
Abbott’s Panbio COVID-19 Ag Rapid Test Receives WHO Clearance for Emergency Use Listing
Automatic Point-of-Care System Measures COVID-19 Antibodies Along with HbA1c, CRP, U-Albumin within 3 Minutes
Qiagen to Complement COVID-19 Testing Portfolio with Novel Kit That Simplifies and Accelerates PCR Analysis for Research
Bacteriophage Analysis Technique Reveals Details of COVID-19’s Impact on the Immune System
New COVID-19 Testing Method Delivers Accurate Results Without Using Reagents
New Sensor Rapidly Detects COVID-19 Infection Status, Severity, and Immunity
Quidel Receives FDA EUA for First Rapid Antigen Combination ABC Test for Influenza A+B and COVID-19
LabCorp’s Innovative SARS-CoV-2 RNA Extraction Method Secures FDA Emergency Use Authorization
Beckman Coulter Granted FDA EUA for COVID-19 Inflammatory Response Immunoassay
New Diagnostic Tool Identifies and Treats COVID-19 Patients at Serious Risk of Developing Cytokine Storm
Vivera Pharmaceuticals Launches Two New COVID-19 Diagnostic Tests for Detection of SARS-CoV-2 Antigens
Huge COVID-19 Testing Demand to Drive Global Point-of-Care Diagnostics Market to USD 11.7 Billion by 2024
